...
首页> 外文期刊>BMC Pulmonary Medicine >Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis
【24h】

Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis

机译:特发性肺纤维化的外泌体Let-7D和miR-16的下调

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Idiopathic Pulmonary Fibrosis (IPF) is a degenerative interstitial lung disease with both a poor prognosis and quality of life once the diagnosis is made. In the last decade many features of the disease have been investigated to better understand the pathological steps that lead to the onset of the disease and, moreover, different types of biomarkers have been tested to find valid diagnostic, prognostic and therapy response predictive ones. In the complexity of IPF, microRNA (miRNAs) biomarker investigation seems to be promising. We analysed the expression of five exosomal miRNAs supposed to have a role in the pathogenesis of the disease from serum of a group of IPF patients (n?=?61) and we compared it with the expression of the same miRNAs in a group of healthy controls (n?=?15). In the current study what emerged is let-7d down-regulation and, unexpectedly, miR-16 significant down-regulation. Moreover, through a cross-sectional analysis, a clustering of the expression of miR-16, miR-21 and miR-26a was found. These findings could help the individuation of previously unknown key players in the pathophysiology of IPF and, most interestingly, more specific targets for the development of effective medications.
机译:特发性肺纤维化(IPF)是一种退行性间质肺病,一旦诊断,既具有较差的预后和生活质量。在过去的十年中,疾病的许多特征已经被研究以更好地了解导致疾病发作的病理步骤,而且已经测试了不同类型的生物标志物,以查找有效的诊断,预后和治疗响应预测性。在IPF的复杂性中,MicroRNA(MIRNA)生物标志物调查似乎很有希望。我们分析了五个外泌体miRNA的表达,该表达应该在来自一组IPF患者的血清的疾病发病机制中具有作用(n?=?61),我们将其与一组健康的表达进行比较控制(n?=?15)。在目前的研究中,出现的是Let-7D下调,意外,MIR-16显着的下调。此外,通过横截面分析,发现了miR-16,miR-21和miR-26a的表达的聚类。这些调查结果可以帮助在IPF的病理生理学中为先前未知的关键参与者提供个性化,以及最有趣的,更具体的目标,以发展有效药物的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号